Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in AVBP — ArriVent BioPharma, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in AVBP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$992,938
+$280,122 QoQ
Shares Held
28,582
-7.5% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 158 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVBP Over Time

Shares Held

Position Value (USD)

Derivatives in AVBP

reported options exposure · as of Jun 30, 2026
CallValue
$17,658,342
CallShares
508,300
PutValue
$976,194
PutShares
28,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. AVBP ranks #126 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AVBP

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $976,194 28,100
2026-06-30 $992,938 28,582
2026-06-30 $17,658,342 508,300
2026-03-31 $712,816 30,898
2026-03-31 $3,022,170 131,000
2026-03-31 $664,416 28,800
2025-12-31 $4,885,699 242,828
2025-09-30 $608,850 33,000
2025-06-30 $644,631 29,611
2025-03-31 $680,265 36,791
2024-12-31 $475,151 17,836